Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma

In pancreatic ductal adenocarcinoma (PDAC), the benefit of current chemotherapy and radiation therapy is very limited, even in radically resected patients. New treatment strategies, for example based on the inhibition of the tumour's blood supply, need to be explored. We have investigated angio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	APMIS : acta pathologica, microbiologica et immunologica Scandinavica microbiologica et immunologica Scandinavica, 2013-11, Vol.121 (11), p.1037-1046
Hauptverfasser:	Hoem, Dag, Straume, Oddbjørn, Immervoll, Heike, Akslen, Lars A., Molven, Anders
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood supply Adenocarcinoma - mortality Adult Aged Aged, 80 and over Angiogenesis Carcinoma, Pancreatic Ductal - blood supply Carcinoma, Pancreatic Ductal - mortality Cell Proliferation Female GMP Humans KRAS mutation Male Middle Aged Mutation MVD Neovascularization, Pathologic - mortality pancreatic cancer Pancreatic Neoplasms - blood supply Pancreatic Neoplasms - mortality Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins p21(ras) ras Proteins - genetics survival VPI
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!